Many reports indicate that AMPK activation promotes survival of tumor cells via NADPH, AMPK–CREB1, and AMPK-mTOR-Akt/ERK signaling pathways (Jeon et al., 2012; Gao et al., 2016; Chhipa et al., 2018). The gene discussed is AKT1; the disease is neoplasm.